{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:01:58Z","timestamp":1788537718237,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201226"],"award-info":[{"award-number":["82201226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xops.2026.101204","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:12:41Z","timestamp":1776899561000},"page":"101204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between Antiretinal Antibodies and OCT Manifestations in Nonparaneoplastic Autoimmune Retinopathy"],"prefix":"10.1016","volume":"6","author":[{"given":"Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenghang","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-9635","authenticated-orcid":false,"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101204_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/IAE.0000000000000119","article-title":"Autoimmune retinopathy and antiretinal antibodies: a review","volume":"34","author":"Grewal","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101204_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","article-title":"Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach","volume":"168","author":"Ar","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12348-019-0171-1","article-title":"Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases","volume":"9","author":"Khanna","year":"2019","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.xops.2026.101204_bib4","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/diagnostics13213376","article-title":"Structural and functional changes in non-paraneoplastic autoimmune retinopathy","volume":"13","author":"Akhavanrezayat","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.xops.2026.101204_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajo.2004.12.104","article-title":"Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies","volume":"139","author":"Weleber","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ajo.2011.09.012","article-title":"Optical coherence tomography findings in autoimmune retinopathy","volume":"153","author":"Abazari","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib7","first-page":"1","article-title":"Comparison of clinical and immunological features of para- and non-paraneoplastic autoimmune retinopathy in Chinese - a series of 48 cases","author":"Zeng","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101204_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bjophthalmol-2012-302524","article-title":"SD-OCT and autofluorescence characteristics of autoimmune retinopathy","volume":"97","author":"Pepple","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/1566524015666150731104626","article-title":"Assessment of retinal structural and functional characteristics in eyes with autoimmune retinopathy","volume":"15","author":"Sepah","year":"2015","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.xops.2026.101204_bib10","first-page":"1","article-title":"Retinal sublayer analysis in autoimmune retinopathy and identification of new optical coherence tomography phenotypes","author":"Fortenbach","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101204_bib11","first-page":"1","article-title":"Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy","volume":"11","author":"Ar","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101204_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2022.07.005","article-title":"Plasma antiretinal autoantibody profiling and diagnostic efficacy in patients with autoimmune retinopathy","volume":"245","author":"Sh","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib13","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00417-019-04359-2","article-title":"Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy","volume":"257","author":"Zeng","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaophthalmol.2021.0651","article-title":"Clinical utility of antiretinal antibody testing","volume":"139","author":"Chen","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/WNO.0b013e318167549f","article-title":"Frequency of anti-retinal antibodies in normal human serum","volume":"28","author":"Shimazaki","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2025.03.024","article-title":"Guidelines for the diagnosis, management, and study of autoimmune retinopathy from the American Academy of Ophthalmology\u2019s task force","author":"Modjtahedi","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101204_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00281-008-0114-7","article-title":"Autoimmune retinopathy: a review and summary","volume":"30","author":"Heckenlively","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.xops.2026.101204_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108317","article-title":"Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy","volume":"210","author":"Adamus","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.xops.2026.101204_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","article-title":"Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies?","volume":"9","author":"Adamus","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2026.101204_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9394(02)01633-1","article-title":"Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy","volume":"134","author":"Ohguro","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib21","first-page":"705","article-title":"Mechanisms of photoreceptor cell death in cancer-associated retinopathy","volume":"42","author":"Maeda","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101204_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2005.11.007","article-title":"Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells","volume":"26","author":"Adamus","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.xops.2026.101204_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/(SICI)1097-4547(19990901)57:5<706::AID-JNR12>3.0.CO;2-G","article-title":"Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro","volume":"57","author":"Chen","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.xops.2026.101204_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.10.023","article-title":"Pathogenic autoantibodies: emerging insights into tissue injury","volume":"103","author":"Lim","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.xops.2026.101204_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/jaut.1998.0221","article-title":"Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo","volume":"11","author":"Adamus","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.xops.2026.101204_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10875-006-9065-8","article-title":"The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy","volume":"27","author":"Magrys","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.xops.2026.101204_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2004.06.003","article-title":"Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy","volume":"23","author":"Ren","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.xops.2026.101204_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2009.02.001","article-title":"Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy","volume":"32","author":"Adamus","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.xops.2026.101204_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.survophthal.2012.09.001","article-title":"Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management","volume":"58","author":"Ehsan","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-14-5","article-title":"A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and \u03b1-enolase","volume":"14","author":"Saito","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2026.101204_bib34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/IAE.0000000000004036","article-title":"Toward an imaging-centric definition of nonparaneoplastic autoimmune retinopathy","volume":"44","author":"Xu","year":"2024","journal-title":"Retina"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:12:16Z","timestamp":1786954336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526001429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666914526001429"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101204","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between Antiretinal Antibodies and OCT Manifestations in Nonparaneoplastic Autoimmune Retinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101204"}}